Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Perspective · 2023 Case report · 3 Oct 2022 Evolution and role of cancer biology and inhibition of metabolism and tumor development.
Cancer goes through a series of events called 'somatic evolution'. A central
Rapid communication · 1 Mar 2022 Cancer Uncovered Lymphatic Endothelial Cells Advance Essential Growth Development by means of IL6
The growth microenvironment (TME) is a perplexing biological system comprising of disease
Conference abstract · 2019 Record linkage of anti-HIV activity and cancer activity match isatin scaffolds attending research and development from medicinal chemistry laboratory
been found to be a useful tool for understanding HIV and Cancer epidemiology in many developed countries of the world (USA, UK, Australia, Italy) and also in Uganda ... matching and databases as well as no combine…
Conference abstract · 3 Sep 2018 Development of self assembled nano carriers for colon cancer
colorectal cancer is the third leading cause of death worldwide. Arginine based peptide nanotubes (soluble) and fibers (gels) have been synthesized by solid phase peptide synthesizer and developed as nanocarriers…
Conference abstract · 2018 Drug development of autophagy-essential protease ATG4 for cancer therapy
Tumor cells require proficient autophagy for high metabolic demand, rapid proliferation and
Conference abstract · 31 Oct 2016 Drug development from bacterial pathogens to fight infections and cancer
It is now well-known that many pathogenic bacteria with long term
Conference abstract · 29 Aug 2016 Developing the midwifes role in public health for cancer control: Prevention and early detection of female cancers, breast and cervix
were 14.1 million new cancer cases (52.7% male; 47.3% female) from which 8.2 million were death cases. Most of new cases (approximately 70%) were from developing countries. In females, breast ... were of breast cancer…
Other · 23 Jul 2016 Ramucirumab: a promising development in advanced non-small cell lung cancer
pathway is a critical target for anti-angiogenic therapy in advanced nonsmall cell lung cancer (NSCLC). Bevacizumab, a monoclonal antibody targeting VEGF-A, is the only anti-angiogenic agent approved ... extracellular…
Review article · 15 Jul 2016 Targeting angiogenesis in non-small-cell lung cancer: a focus on current approaches and future developments
number of clinical indications and agents that are in development is extraordinary. A lot of questions regarding angiogenesis in cancer still remain unanswered. One of the major weaknesses ... most current clinical…
Research article · 29 Jan 2016 The Relative Efficacies and Developments in Adjuvant and Neoadjuvant Therapy for Gastric Cancer - Review
This present study examined the efficacy and developments in gastric cancer modalities. This is in light of the fact that gastric cancer accounts for a significant number of cancer related ... deployment of these…
Conference abstract · 2016 Prognostic microRNA signature of triple-negative breast cancer identified by cross-validated Cox model development
found its clinical success in applications. This study illustrated how an improper model develop or testing procedure could mislead the result and applied the proper cross-validated (CV) Cox model ... testing procedure…
Conference abstract · 5 Oct 2015 New developments in the diagnosis and treatment of thyroid cancer
diagnosis, work-up, and advanced treatment of both differentiated and medullary thyroid cancers, focusing specifically on newer developments in the field
Conference abstract · 15 Oct 2013 Development of novel antiestrogenic estrone analogs targeting breast cancer
human breast cancer and most cases of breast cancer (60%-80%) composed of the luminal/estrogen-α positive (ERα +) tumors. Therefore, development of anti- estrogenic compounds ... ligands to estrogen receptor/molecular…
Conference abstract · 10 Jul 2013 Development of target-specific theranostic agents for cancer treatment
Conference abstract · 20 Jun 2013 Cancer stem cells: Implications for colon carcinogenesis and development of therapeutic strategies with natural agents
CSCs is their resistance to 5-FU based chemotherapy, the mainstay of colon cancer therapeutic with significant toxicities, resulting in high disease recurrence underscoring the need for improved CSC-targeted…
Article · 2013 New Developments in the Management of Borderline Resectable Pancreatic Cancers
There remains great variability in the treatment for patients with borderline resectable
Article · 2013 New Developments in the Management of Borderline Resectable Pancreatic Cancer
The optimal management of borderline resectable pancreatic cancer remains unclear. Neoadjuvant chemoradiation
Article · 2009 New Developments in the Treatment of Locally Advanced Pancreatic Cancer Highlights from the Ã?¢Ã?â?¬Ã?Å?45 th ASCO Annual MeetingÃ?¢Ã?â?¬Ã?. Orlando, FL, USA. May 29 - June 2, 2009
The results of the trials presented at this year’s ASCO annual
Conference abstract Development of self-assembled nanocarriers for colon cancer
colorectal cancer is the third leading cause of death worldwide. Arginine based peptide nanotubes (soluble) and fibers (gels) have been synthesized by solid phase peptide synthesizer and developed as nanocarriers…
Conference abstract Development of a high-efficiency anti-cancer fusion vaccine protein production system using Chinese cabbage
mass production by agriculture system. To acquire edible vaccine fusion protein for colorectal cancer which is a serious disease in worldwide, we used various form of immunoglobulin ... vegetable, oilseed and fodder…
Conference abstract Development of Potent Inhibitory Phage Vaccine against Prostate Cancer
In this research we pursue a less studied strategy of using PSMA
Conference abstract Development of an anti-idiotypic Mab as cancer vaccine: From discovery to approval
melanoma and breast cancer. Recently this product was approved for treatment for NSLC by regulatory authorities in Cuba and Argentina. This study describethe novel and complete development strategy allowed taking

